ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.R., OreopoulosD.G., PageD.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada–USA (CANUSA) Peritoneal Dialysis Study Group.J Am Soc Nephrol1998; 9: 1285–92.
2.
NKF-DOQI clinical practice guidelines for hemodialysis adequacy.National Kidney Foundation.Am J Kidney Dis1997; 30(Suppl 2): S15–66.
3.
MujaisS., NolphK., GokalR., BlakeP., BurkartJ., ColesG.Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.Perit Dial Int2000; 20(Suppl 4): S5–21.
4.
LameireN., VanholderR.C., Van LooA., LambertM.C., VijtD., Van BockstaeleL.Cardiovascular diseases in peritoneal dialysis patients: The size of the problem.Kidney Int Suppl1996; 56: S28–36.
5.
OzkahyaM., OkE., CiritM., AydinS., AkcicekF., BasciA.Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs.Nephrol Dial Transplant1998; 13: 1489–93.
6.
PaniaguaR., AmatoD., VoneshE., Correa–RotterR., RamosA., MoranJ.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis. ADEMEX: A prospective, randomized, controlled trial.J Am Soc Nephrol2002; 13: 1307–20.
7.
BargmanJ.M., ThorpeK.E., ChurchillD.N.Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA Study.J Am Soc Nephrol2001; 12: 2158–62.
8.
WangT., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients.Nephrol Dial Transplant1998; 13: 1242–9.
9.
LameireN., Van BiesenW.Importance of blood pressure and volume control in peritoneal dialysis patients.Perit Dial Int2001; 21: 206–11.
10.
ColesG.A.Have we underestimated the importance of fluid balance for the survival of PD patients?Perit Dial Int1997; 17: 321–6.
11.
BurkartJ.M.What is the evidence that peritoneal dialysis is underutilized as an ESRD therapy?Semin Dial2002; 16: 157–61.
12.
CannataJ.B., IslesC.G., BriggsJ.D., JunorB.J.R.Comparison of blood pressure control during hemodialysis and CAPD.Dial Transplant1986; 15: 675–9.
13.
CocchiR., EspostiE.D., FabbriA., LucatelloA., SturaniA., QuarelloF.Prevalence of hypertension in patients on peritoneal dialysis: Results of an Italian multicentre study.Nephrol Dial Transplant1999; 14: 1536–40.
14.
VelasquezM.T., LewS.Q., von AlbertiniB., MishkinG.J., BoschJ.P.Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.Clin Nephrol1997; 48: 341–5.
15.
IssadB., MouquetC., BitkerM.O., AllouacheM., BaumelouA., RottembourgJ.Is overhydration in CAPD patients a contraindication to renal transplantation?Adv Perit Dial1994; 10: 68–72.
16.
KoningsCJAM, KoomanJ.P., SchonckM., DammersR., CheriexE., Palmans–MeulemansA.Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis.Perit Dial Int2002; 22: 477–87.
17.
EniaG., MallamaciF., BenedettoF.A., PanuccioV., ParlongoS., CutrupiS.Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients.Nephrol Dial Transplant2001; 16: 1459–64.
18.
PlumJ., SchoenickeG., KleophasW., KulasW., SteffensF., AzemA.Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods.Nephrol Dial Transplant2001; 16: 2378–85.
19.
AtesK., NergizogluG., KevenK., SenA., KutlayS., ErturkS.Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.Kidney Int2001; 60: 767–76.
20.
KoningsCJAM, KoomanJ.P., SchonckM., StruijkS.G., GladziwaU., HoorntjeS.J.Fluid status in CAPD patients is related to peritoneal transport and residual renal function: Evidence from a longitudinal study.Nephrol Dial Transplant2003; 18: 797–803.
21.
NiebauerJ., VolkH.D., KempM., DominguezM., SchumannR.R., RauchhausM.Endotoxin and immune activation in chronic heart failure: A prospective cohort study.Lancet1999; 353: 1838–42.
22.
WoodrowG., OldroydB., StablesG., GibsonJ., TurneyJ.H., BrownjohnA.M.Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis.Nephrol Dial Transplant2000; 15: 862–6.
23.
GunalA.I., DumanS., OzkahyaM., TozH., AsciG., AkcicekF.Strict volume control normalizes hypertension in peritoneal dialysis patients.Am J Kidney Dis2001; 37: 588–93.
24.
LuikA.J., KoomanJ.P., LeunissenK.M.Hypertension in haemodialysis patients: Is it only hypervolaemia?Nephrol Dial Transplant1997; 12: 1557–60.
25.
LangS.M., WolframG., GerzerR., SchifflH.Characterization of subtypes of hypertension in CAPD patients by cyclic guanosine monophosphate.Perit Dial Int1999; 19: 143–7.
26.
KouwP.M., KoomanJ.P., CheriexE.C., OlthofC.G., de VriesP.M., LeunissenK.M.Assessment of postdialysis dry weight: A comparison of techniques.J Am Soc Nephrol1993; 4: 98–104.
27.
Cox–ReijvenP.L., KoomanJ.P., SoetersP.B., van Der SandeF.M., LeunissenK.M.Role of bioimpedance spectroscopy in assessment of body water compartments in hemodialysis patients.Am J Kidney Dis2001; 38: 832–8.
28.
KoningsCJAM, KoomanJ.P., SchonckM., Cox–ReijvenP.L., van KreelB., GladziwaU.Assessment of fluid status in peritoneal dialysis patients.Perit Dial Int2002; 22: 683–92.
29.
ZhuF., SchneditzD., KaufmanA.M., LevinN.W.Estimation of body fluid changes during peritoneal dialysis by segmental bioimpedance analysis.Kidney Int2000; 57: 299–306.
30.
TzamaloukasA.H., SaddlerM.C., MurataG.H., MalhotraD., SenaP., SimonD.Symptomatic fluid retention in patients on continuous peritoneal dialysis.J Am Soc Nephrol1995; 6: 198–206.
31.
ChamneyP.W., KramerM., RodeC., KleinekofortW., WizemannV.A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance.Kidney Int2002; 61: 2250–8.
32.
DaviesS.J.Monitoring of long-term peritoneal membrane function.Perit Dial Int2001; 21: 225–30.
33.
BosW.J., StruijkD.G., van OldenR.W., AriszL., KredietR.T.Elevated 24-hour blood pressure in peritoneal dialysis patients with ultrafiltration failure.Adv Perit Dial1998; 14: 108–10.
34.
WangA.Y., WangM., WooJ., LawM.C., ChowK.M., LiP.K.A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.Kidney Int2002; 62: 639–47.
35.
KredietR.T., ZweersM.M., van der WalA.C., StruijkD.G.Neoangiogenesis in the peritoneal membrane.Perit Dial Int2000; 20(Suppl 2): S19–25.
36.
De VrieseA.S., MortierS., LameireN.H.What happens to the peritoneal membrane in long-term peritoneal dialysis?Perit Dial Int2001; 21(Suppl 3): S9–18.
37.
DaviesS.J., PhillipsL., NaishP.F., RussellG.I.Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.J Am Soc Nephrol2001; 12: 1046–51.
38.
MateijsenM.A., van der WalA.C., HendriksP.M., ZweersM.M., MulderJ., StruijkD.G.Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis.Perit Dial Int1999; 19: 517–25.
Ho-dac-PannekeetM.M., AtaseverB., StruijkD.G., KredietR.T.Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis.Perit Dial Int1997; 17: 144–50.
41.
FusshollerA., zur NiedenS., GrabenseeB., PlumJ.Peritoneal fluid and solute transport: Influence of treatment time, peritoneal dialysis modality, and peritonitis incidence.J Am Soc Nephrol2002; 13: 1055–60.
42.
HeimbürgerO., WaniewskiJ., WerynskiA., TranæusA., LindholmB.Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.Kidney Int1990; 38: 495–506.
43.
ChungS.H., HeimbürgerO., StenvinkelP., BergströmJ., LindholmB.Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis.Nephrol Dial Transplant2001; 16: 2240–5.
44.
MenonM.K., NaimarkD.M., BargmanJ.M., VasS.I., OreopoulosD.G.Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function.Nephrol Dial Transplant2001; 16: 2207–13.
45.
TakedaK., NakamotoM., BabaM., TanakaT., YasunagaC., NishiharaG.Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.Clin Nephrol1998; 49: 308–12.
46.
JonesC.H., WellsL., StovesJ., FarquharF., WoodrowG.Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients?Am J Kidney Dis2002; 39: 872–5.
47.
KoningsC.J., KoomanJ.P., SchonckM., GladziwaU., WirtzJ., GerlagP.G.Effect of icodextrin on volume state, blood pressure and echocardiographic parameters: A randomized study.Kidney Int2003; 63: 1556–63.
WigandM.E., HeidlandA.Ototoxic side effects of high doses of furosemide in patients with uraemia.Postgrad Med J1971; 47(Suppl): 54–6.
50.
van OldenR.W., van MeyelJ.J., GerlagP.G.Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients.Am J Nephrol1992; 12: 351–6.
51.
BredieS.J., BoschF.H., DemackerP.N., StalenhoefA.F., van LeusenR.Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism.Perit Dial Int2001; 21: 275–81.
52.
ZhengZ.H., SederholmF., AnderstamB., QureshiA.R., WangT., SoderstenP.Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats.Kidney Int2001; 60: 2392–8.
53.
Diaz-BuxoJ.A.Continuous cycling peritoneal dialysis, PD Plus, and high-flow automated peritoneal dialysis: A spectrum of therapies.Perit Dial Int2000; 20(Suppl 2): S93–7.
WangM.C., TsengC.C., TsaiW.C., HuangJ.J.Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens.Perit Dial Int2001; 21: 36–42.
56.
OrtegaO., GallarP., CarrenoA., GutierrezM., RodriguezI., OlietA.Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: Influence on blood pressure control.Am J Nephrol2001; 21: 189–93.
57.
MistryC.D., GokalR., PeersE.A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.Kidney Int1994; 46: 496–503.
58.
PosthumaN., ter WeeP.M., DonkerA.J., OeP.L., PeersE.M., VerbrughH.A.Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.Perit Dial Int2000; 20(Suppl 2): S106–13.
59.
PlumJ., GentileS., VergerC., BrunkhorstR., BahnerU., FallerB.Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.Am J Kidney Dis2002; 39: 862–71.
60.
JohnsonD.W., ArndtM., O'SheaA., WattR., HamiltonJ., VincentK.Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.BMC Nephrol2001; 2: 2.
61.
Araujo TeixeiraM.R., Pecoits–FilhoR.F., Romao JuniorJ.E., SabbagaE., MarcondesM.M., AbensurH.The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.Perit Dial Int2002; 22: 229–33.
62.
DaviesS.J., WoodrowG., PlumJ., HeimbürgerO., DonovanK., DivinoJ.Icodextrin improves fluid status in PD patients [Abstract].J Am Soc Nephrol2002; 13: 623A.
63.
Passlick–DeetjenJ., SchaubT.P., SchillingH.Solutions for APD: Special considerations.Semin Dial2002; 15: 407–13.
HekkingL.H., ZareieM., DriesprongB.A., FaictD., WeltenA.G., de GreeuwI.Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.J Am Soc Nephrol2001; 12: 2775–86.
66.
ZeierM., SchwengerV., DeppischR., HaugU., WeigelK., BahnerU.Glucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation?Kidney Int2003; 63: 298–305.
67.
MortierS., De VrieseA.S., Van de VoordeJ., SchaubT.P., Passlick–DeetjenJ., LameireN.H.Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products.J Am Soc Nephrol2002; 13: 480–9.
68.
RippeB., SimonsenO., HeimbürgerO., ChristenssonA., HaraldssonB., StelinG.Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.Kidney Int2001; 59: 348–57.
69.
CookerL.A., LuneburgP., HolmesC.J., JonesS., TopleyN.Bicarbonate/Lactate Study Group. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.Perit Dial Int2001; 21(Suppl 3): S102–7.
70.
JonesS., HolmesC.J., KredietR.T., MackenzieR., FaictD., TranæusA.Bicarbonate/Lactate Study Group. Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels.Kidney Int2001; 59: 1529.
